# Dose Assessment of Melatonin in Sepsis Trial

> **NCT02319265** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Aberdeen**

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Melatonin

## Key facts

- **NCT ID:** NCT02319265
- **Lead sponsor:** University of Aberdeen
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-04
- **Primary completion:** 2019-06
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study registered elsewhere and is not covered by FDA
- **Last updated:** 2017-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02319265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02319265, "Dose Assessment of Melatonin in Sepsis Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02319265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*